Wikidata

(Q66404694)

English

Daratumumab in Combination With ATRA

clinical trial

In more languages

Statements

short name
DARA/ATRA (English)
0 references
title
A Phase 1 and Phase 2 Study of Daratumumab in Combination With All-trans Retinoic Acid in Relapsed/Refractory Multiple Myeloma (English)
0 references
country
Netherlands
0 references
start time
6 July 2016
0 references
end time
1 May 2019
0 references
number of participants
60
0 references
research intervention
daratumumab
0 references
tretinoin
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q66404694&oldid=1881830244"